It was assessed the influence of aterogenic dislipoproteinemia on recurrent angina pectoris after stricture formation of coronary arteries (CA) in patients with IHD at prolonged (14 months) therapy witsymvastatin and without it. After stricture formation of CA in 14 months 60 patients with IHD have been examined. In 1st group 29 patients were treated with symvastanin in a dose of 20 mg per a day after stricture formation of CA, in 2nd group (the controls) 31 patients haven't been given statins. Dynamics of lipid spectrum, frequency of recurrent angina pectoris, restenosis and AIM, confirmed angyographically were assessed. In 14 months of stricture formation of CA in 1st group there wasn't recurrent angina pectoris in 69% of patients at the background of decreased aterogenic lipid spectrum, in 2nd group this index composed 49%. As it was revealed statins gave higanti-ishemic efficacy in the most patients, decreasinrecurrent angina pectoris in three times and TFN by 69,6%. In 1st group there were no deaths, one patient (3,5%) had AIM. In 2nd group after some period two patients (6,5%) had AIM, one patient had died. Frequency of restenosis composed 12 and 41%, correspondingly, need in repeated revascularization was in 2,7 times lower in patients, treated with statins.
分享
引用
